Carlyle Reports Purchase Of Involta, No Terms Disclosed
Global investment firm Carlyle (NASDAQ:CG) announced today that funds managed by Carlyle have agreed to acquire Involta, a data center company focused on hybrid IT and cloud infrastructure, including data center
Carlyle to Acquire Altadia Group from Lone Star; Terms Not Disclosed
Carlyle (NASDAQ: CG) announced today that it has agreed to acquire Altadia Group ("Altadia") from an affiliate of Lone Star Funds ("Lone Star"), partnering with current management, led by Vincente Bagan and Antonio Blasco, the original founders of Itaca.
Carlyle Group Acquired 50% Stake in Medical-Device Maker Resonetics
-Bloomberg
https://www.bloomberg.com/news/articles/2021-12-03/carlyle-acquires-50-stake-in-medical-device-maker-resonetics
Disney Names Susan Arnold As Successor To Bob Iger For Board Chair
Walt Disney Co.’s (NYSE: DIS) board of directors has named Susan Arnold as its new chairman, the media and entertainment conglomerate said Wednesday.
Earnings Scheduled For November 5, 2021
Companies Reporting Before The Bell
• Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter.
Oppenheimer Maintains Outperform on Carlyle Group, Raises Price Target to $77
Oppenheimer analyst Chris Kotowski maintains Carlyle Group (NASDAQ:CG) with a Outperform and raises the price target from $69 to $77.
Earnings Scheduled For October 28, 2021
Companies Reporting Before The Bell
• LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million.
Carlyle, KKR Said to be Among Firms Considering bid for Hong Kong’s Tricor
-Bloomberg
https://www.bloomberg.com/news/articles/2021-10-21/buyout-firms-said-to-consider-bids-for-2-billion-tricor-sale
Saama Technologies Reports Carlyle Made Strategic Investment In Co., Will Acquire Majority Stake, No Terms Disclosed
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health